PO.TB10.15 · 肿瘤生物学

Muscle iron overload contributes to cancer cachexia-induced muscle wasting

海报缩略图:Muscle iron overload contributes to cancer cachexia-induced muscle wasting
编号 3366 展板 27 时间 4/20 02:00–05:00 区域 Section 26 主讲 Subin Pyo
分会场 Extracellular Vesicles and Long-Range Tumor-Host Communication
查看完整资料 下载 PDF 登录后可访问当前开放资料 AACR 官方页面 ↗

作者与单位

Subin Pyo1, Yichi Zhang1, Anna Barbeau1, ChiHin Feng1, Amit Roopan1, Ning Liu2, Eric N. Olson2, Matthew G. Vander Heiden1

1Biology, Koch Inst. for Integrative Cancer Research at MIT, Cambridge, MA,2Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX

摘要 Abstract

Cancer cachexia is a prevalent and often fatal systemic metabolic condition that is characterized by muscle wasting with or without fat wasting. Muscle wasting is therefore the central component of cancer cachexia but the mechanisms whereby cancer leads to skeletal muscle wasting are not well understood. We used several different mouse models of pancreatic ductal adenocarcinoma (PDAC) as well as C26 allograft, one of the most commonly studied models of cancer cachexia, to study the mechanisms underlying cancer cachexia-induced muscle wasting. Transcriptome analyses on cachexic muscle revealed the upregulation of genes related to iron metabolism. To interrogate whether perturbations to muscle iron metabolism can contribute to muscle wasting, we identified that muscle iron levels are elevated in cachexic muscle. Secondly, mice fed low, medium, and high iron diets and showed a positive correlation between dietary iron intake and the severity of muscle wasting. We further demonstrated that increased muscle iron contributes to muscle wasting by generating muscle-specific transgenic mice overexpressing the transferrin receptor (TFRC), which is the primary method of iron intake into the cell. TFRC transgenic mice exhibited decreased muscle mass and myofiber areas compared to mice not overexpressing TFRC. TFRC transgenic mice injected with C26 cancer cells also showed increased muscle wasting compared to control mice with C26 cells. Furthermore, muscle-specific deletion of TFRC in muscle using a muscle-specific tamoxifen-inducible Cre mouse line bred to a conditional TFRC floxed mouse line rescued C26-induced muscle wasting. Our work rigorously demonstrates that elevated muscle iron leads to muscle wasting, and this elevated muscle iron in cancer cachexic muscle contributes to cancer cachexia-induced muscle wasting. Current work is being done to test whether elevated muscle iron is seen in human samples and to decipher the mechanisms by which muscle iron overload leads to muscle wasting.
利益披露 Disclosure
S. Pyo, None.. Y. Zhang, None.. A. Barbeau, None.. C. Feng, None.. A. Roopan, None.. N. Liu, None.. E. N. Olson, None.. M. G. Vander Heiden, None.

在会议检索中打开